SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration Under
Section 12(g) of the Securities Exchange Act of 1934 or
Suspension of Duty to File Reports Under Sections 13 and 15(d)
of the Securities Exchange Act of 1934
Commission File Number 0-23059
Healthworld Corporation
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
100 Avenue of the Americas, New York, New York 10013
(212) 625-4000
-------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, $.01 par value
----------------------------------------------------------
(Title of each class of securities covered by this Form)
- --------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to
file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [ ] Rule 12h-3(b)(1)(i) [X]
Rule 12g-4(a)(1)(ii) [ ] Rule l2h-3(b)(2)(ii) [ ]
Rule l2g-4(a)(2)(i) [ ] Rule l2h-3(b)(2)(i) [ ]
Rule l2g-4(a)(2)(ii) [ ] Rule l2h-3(b)(2)(ii) [ ]
Rule l5d-6 [ ]
Approximate number of holders of record as of the certification or notice
date: 1
------
Pursuant to the requirements of the Securities Exchange Act of 1934,
Healthworld Corporation has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Dated: March 6, 2000 HEALTHWORLD CORPORATION
By: /s/ Stuart Diamond
--------------------------------------
Name: Stuart Diamond
Title: Executive Vice President,
Secretary and Chief Financial
Officer
